Most patients with decompensated cirrhosis who received inadequate prognostic information about their condition reported higher symptom burden and lower HRQOL.
Although all patients with NAFLD need aggressive management of cardiovascular risk factors, it is only patients with NASH who need treatment targeted at the liver disease. None of the currently ...
Nonalcoholic fatty liver disease (NAFLD) and its progressive form ... the pathogenesis of NAFLD and the current treatment and management of nonalcoholic steatohepatitis. Currently, maintaining ...
The Medical City (TMC) and the Rizal Medical Center (RMC) sign a partnership that will allow TMC to share its knowledge, equipment, and facilities to RMC on liver transplantation. Health Secretary ...
Microbiome Changes in Chronic Liver Disease Highlight the Need for Personalized Treatment Nov. 18, 2024 — People with chronic liver disease have dramatic changes to the types and functions of ...